Universiti Kebangsaan Malaysia Medical Centre, Department of Internal Medicine, Kuala Lumpur, Malaysia.
Universiti Kebangsaan Malaysia Medical Centre, Department of Community Health, Kuala Lumpur, Malaysia.
Med J Malaysia. 2022 Jul;77(4):440-445.
Mortality of Klebsiella pneumoniae (K. pneumoniae) bacteraemia was reported to be on the rise globally. The 30-day mortality rate of K. pneumoniae bacteraemia ranges from 16% to 55% in Beijing, Shanghai, and Taiwan. However, there is a lack of research on the survival outcomes of K. pneumoniae bacteraemia in Malaysia. The objectives of this study were to determine the poor prognostic factors and predictors of 14-day in-hospital mortality from K. pneumoniae bacteraemia.
This was a retrospective cohort study of patients with K. pneumoniae bacteraemia in Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM). We included adult patients with blood cultures positive for K. pneumoniae between 1 January 2016 and 31 December 2019. Those with polymicrobial bacteraemia were excluded. Medical records were reviewed to obtain the sociodemographic data, gender, underlying comorbidities, invasive procedures at presentation, sources of bacteraemia, and whether appropriate empirical and definitive antibiotics was given on time. Data regarding complications of K. pneumoniae bacteraemia, including liver abscess, endopthalmitis, septic shock, Quick Pitt (qPitt) bacteraemia score defined as hypothermia, hypotension, respiratory failure, cardiac arrest, and altered mental status and stay in intensive care unit (ICU) were also recorded. The main outcome measure used was the survival in 14 days. Summary of statistical analysis was done.
A total of 260 patients with K. pneumoniae bacteraemia were included. All patients received appropriate empirical and definitive antibiotics within 24 h of the time that the sample for index blood cultures was obtained. Respiratory infection, septic shock, qPitt bacteraemia score ≥2, solid organ malignancy, stay in ICU, central venous line insertion at presentation, urinary catheterisation at presentation, and in-patient mechanical ventilation were identified as independent predictors of mortality in K. pneumoniae bacteraemia. The rate of complications such as liver abscess, endophthalmitis, ICU admission, and septic shock was not significantly different between survivors and non-survivors. The 14-day in-hospital mortality rate was 12.3%. The median length of hospitalisation was 11 days (IQR 6 - 19) . The predictors of poor prognosis for 14 days in-hospital mortality for K. pneumoniae bacteraemia were as follows: qPitt bacteraemia score ≥2, central venous line insertion, indwelling urinary catheter at presentation, and in-patient mechanical ventilation. Timing from K. pneumoniae bacteraemia event to death among those qPitt bacteraemia scores ≥2 was only for 9 days or less.
The 14-day in-hospital mortality of patients with K. pneumoniae bacteraemia in our setting was low. The qPitt bacteraemia score ≥2 was the strongest predictor of poor prognosis for 14-day in-hospital mortality in patients with K. pneumoniae bacteraemia. The qPitt bacteraemia score should be proposed to be used as a bedside screening tool for gram negative bacteraemia in our daily clinical practice, which is also useful for predicting mortality in critically ill patients.
全球报道称肺炎克雷伯菌(K. pneumoniae)菌血症的死亡率呈上升趋势。北京、上海和中国台湾的肺炎克雷伯菌菌血症 30 天死亡率在 16%至 55%之间。然而,马来西亚缺乏关于肺炎克雷伯菌菌血症生存结果的研究。本研究的目的是确定肺炎克雷伯菌菌血症的 14 天院内死亡率的不良预后因素和预测因素。
这是对马来西亚Universiti Kebangsaan Malaysia Canselor Tuanku Muhriz 医院(HCTM)肺炎克雷伯菌菌血症患者的回顾性队列研究。我们纳入了 2016 年 1 月 1 日至 2019 年 12 月 31 日期间血培养阳性的肺炎克雷伯菌的成年患者。排除了多种微生物菌血症患者。审查病历以获取社会人口统计学数据、性别、潜在合并症、就诊时的侵入性操作、菌血症来源以及是否及时给予适当的经验性和确定性抗生素。还记录了肺炎克雷伯菌菌血症并发症的数据,包括肝脓肿、眼内炎、感染性休克、快速皮特(qPitt)菌血症评分定义为体温过低、低血压、呼吸衰竭、心脏骤停和精神状态改变以及入住重症监护病房(ICU)。主要观察指标为 14 天的生存率。进行了总结性统计分析。
共纳入 260 例肺炎克雷伯菌菌血症患者。所有患者在获得指数血培养样本后 24 小时内均接受了适当的经验性和确定性抗生素治疗。呼吸道感染、感染性休克、qPitt 菌血症评分≥2、实体器官恶性肿瘤、入住 ICU、就诊时中央静脉置管、就诊时导尿和住院机械通气被确定为肺炎克雷伯菌菌血症死亡的独立预测因素。幸存者和非幸存者之间肝脓肿、眼内炎、入住 ICU 和感染性休克等并发症的发生率没有显著差异。14 天院内死亡率为 12.3%。住院中位数为 11 天(IQR 6-19)。肺炎克雷伯菌菌血症 14 天院内死亡率不良预后的预测因素如下:qPitt 菌血症评分≥2、中央静脉置管、就诊时留置导尿管和住院机械通气。qPitt 菌血症评分≥2 的患者从肺炎克雷伯菌菌血症事件到死亡的时间仅为 9 天或更短。
我们研究环境中肺炎克雷伯菌菌血症患者的 14 天院内死亡率较低。qPitt 菌血症评分≥2 是肺炎克雷伯菌菌血症患者 14 天院内死亡率不良预后的最强预测因素。qPitt 菌血症评分应被提议作为我们日常临床实践中革兰氏阴性菌血症的床边筛查工具,对危重症患者的死亡率预测也很有用。